home technology applications about us news
deltaDOT is a spin out company from Imperial College London UK - a team of scientists and  engineers dedicated to the advancement of analytical techniques using patented methods and  instrumentation in High Performance Capillary Electrophoresis (HPCE). We design and  produce HPCE instruments which we are marketing worldwide. We also use the same  instruments to offer Analytical Services and Contract Research. Our offices and laboratories  are based in the London Bioscience Innovation Centre (LBIC). 
Who we are 
HPCE instruments 
High Performance Capillary Electrophoresis (HPCE) analytical instruments are designed,  manufactured and marketed by deltaDOT. These instruments use deltaDOT’s proprietary  imaging and analysis technology called Label Free Intrinsic Imaging (LFII®). High  Performance Capillary Electrophoresis and Label Free Intrinsic Imaging applied to a CE  analytical system  offers dramatically improved discovery power in comparison to other  conventional CE systems.
deltaDOT’s team of scientists has developed a considerable expertise in CE based analysis  and in solving clients’ analytical problems. Using our own HPCE LFII® analytical instruments  we also offer Analytical Services, Contract Research and Scientific Collaboration to industry  and academia from our laboratories at the London Bioscience Innovation Centre. Our recent  and current collaboration examples include those shown below. 
Analytical Services Contract Research Scientific Collaboration 
HPCE Applications 
High Performance Capillary Electrophoresis (HPCE) is applied in Life Sciences research, drug  testing, diagnostics and bio-pharmaceutical manufacturing. This technology is used in  detection, separation and analysis of proteins, nucleic acids, carbohydrates, viruses and  bacteria, chemicals and a wide range of other analytes. More detail can be found on our  Technology pages. 
Application Notes Downloads Quick Update 
Antibody Analysis, Amino Acid Analysis, Transferrin, Small Molecules, Peptides, Complex Protein Lysates, Recombinant Human Erythropoietin, Antibiotics in food products, Glycoforms, DNA, RNA, Chemicals, Baculovirus Titre. Glomerular filtration rate (GFR) determined by Iohexol clearance was developed in  collaboration with Royal Veterinary College for renal failure diagnosis in companion animals  (...more) 
18 January 2018 deltaDOT Ltd. announce successful licensing of their High Performance  Capillary Electrophoresis technology (HPCE) to a leading Chinese company. Last month  deltaDOT entered into a collaboration agreement with a Chinese partner to purchase all  deltaDOT’s technical know-how, software and IP licenses for their High Performance Capillary  Electrophoresis (HPCE) technology (...more)  18 December 2017 The subject of the new Technology partnership publication by deltaDOT is  Glatiramer Acetate Analysis as applied in immunomodulator treatment for multiple sclerosis. On  demand analytics of high quality and cost effective nature are described in this application note  (...more)  13 October 2017 deltaDOT continues with Technology partnership publication (www.ttp.com)  The TTP Journal of Technology and Business Innovation provides technical insight into UK  advanced scientific businesses. New articles are now available on Water Ionic Analysis (...more)  and Nicotine Analysis (...more).  8 September 2017 deltaDOT are launching a new series of articles dD Techniques on the  capabilities of their High Performance Label Free Imaging Capillary Electrophoresis technology.  The articles offer accessible information and an insight into this unique technology which is used  worldwide to solve challenging analytical problems. A new perspective on the tools required for  the development and manufacture of monoclonal antibodies, biosimilars, stratified therapies,  viral vaccines and gene therapy vectors highlights the need for new analytical techniques.  These new perspectives are the aims which dD Techniques articles intend to deliver to a wide  range of audience (...links to article1, article2, article3)  24 August 2017 The Technology partnership publication (www.ttp.com) now includes key facts  and data on deltaDOT’s High Precision Capillary Electrophoresis advanced technology. The TTP  Journal of Technology and Business Innovation provides technical insight into UK advanced  scientific businesses (...more) 3rd July 2017 Future Targeted Healthcare Manufacturing. deltaDOT announce their  participation in the new EPSRC funded Future Targeted Healthcare Manufacturing Hub, led by  UCL (...more). The Hub will address the manufacturing, business and regulatory challenges to  ensure that new targeted biological medicines can be developed quickly and manufactured at  affordable costs (...more).   24th January 2017 – deltaDOT Ltd. announces compliance with CFR 21 part 11 of USA’s Food  and Drug Administration. deltaDOT now offers an upgraded version of its control and analysis  software which has been designed to aid users of deltaDOT’s HPCE-512 Hig Performance  Capillary Electrophoresis instrument in achieving compliance with CFR 21 part 11.The upgrade  package contains controls to help meet the stringent requirements of CFR 21 part 11 including  the system access by authorised personel only, maintaining audit trails of user actions,  generating complete and protected data files and the application of electronic signatures to data  (...more)  20 Sep 2016 National Health Service Quality Control North West (QCNW) Liverpool  labs  presented the data on monoclonal antibody stability trials based on deltaDOT’s Capillary  Electrophoresis (CE) technology  and expertise. They state that CE technology is suitable for  monitoring the stability of monoclonal antibodies and can perform purity and charge analysis with  high resolution and repeatability. They conclude that CE can replace other techniques commonly  used for this analysis IEC and SDS PAGE (link to the poster).  3rd July 2016 Monoclonal Antibody Stability Trials using deltaDOT HPCE-512 technology  reported by Dr. Deepika Devanur. Now available in pdf slide format on our website (...more)